Table 3—

Univariate survival analyses performed in the different groups and different histological subtypes

Histological subtypesStagesType of analysisMedian survival months5-yr survival %p-value
BC versus non-BCAll patientsOverall survival29 versus 3426 versus 380.05
BC versus non-BCAll patientsDisease specific45 versus NR41 versus 590.014
BC versus non-BCStages I and IIOverall survival29 versus 4927 versus 440.01
BC versus non-BCStages I and II#Overall survival37 versus NR30 versus 470.03
BC versus non-BCStages I and IIDisease specific49 versus NR45 versus 650.008
BC versus non-BCStage IOverall survival36 versus NR33 versus 510.01
BC versus SCCAll patientsOverall survival29 versus 3326 versus 370.15
BC versus SCCAll patientsDisease specific45 versus NR41 versus 610.005
BC versus SCCStage I+Overall survival36 versus NR33 versus 510.02
Basaloid variants of SCC versus SCCStage IOverall survival37 versus NR36 versus 510.19

  • BC: lung carcinomas with a basaloid pattern; non-BC: nonbasaloid carcinoma; SCC: squamous cell carcinoma; NR: not reached. #: patients who died within 30 days after surgery were excluded; : see figure 2⇑; +: see figure 3⇑.